NCT05763069 - HOME: Home Monitoring of High-risk Pregnancies | Biotech Hunter

Enrollment

224

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

September 30, 2035

Study Completion Date

September 30, 2040

Conditions

Hypertensive Disorder of PregnancyPremature Preterm Rupture of MembranesPreeclampsiaHigh Risk PregnancyPrevious Adverse Obstetric Outcome

Interventions

OTHER

Home surveillance of pregnancies at risk

Offer women with pregnancies at risk home surveillance instaed of more frequent hospital out-patient visits and/or hospitalisation: cardiotocographia (CTG), patient measurements of CRP, temperature, blood pressure, and clinical signs of infection or severe forms of preeclampsia.

Trial Locations (1)

0424

Oslo University Hospital, Oslo